BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 16790421)

  • 1. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation.
    Ayrapetov MK; Wang YH; Lin X; Gu X; Parang K; Sun G
    J Biol Chem; 2006 Aug; 281(33):23776-84. PubMed ID: 16790421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.
    Bibbins KB; Boeuf H; Varmus HE
    Mol Cell Biol; 1993 Dec; 13(12):7278-87. PubMed ID: 7504171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.
    Ayrapetov MK; Nam NH; Ye G; Kumar A; Parang K; Sun G
    J Biol Chem; 2005 Jul; 280(27):25780-7. PubMed ID: 15890649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calorimetric examination of high-affinity Src SH2 domain-tyrosyl phosphopeptide binding: dissection of the phosphopeptide sequence specificity and coupling energetics.
    Bradshaw JM; Waksman G
    Biochemistry; 1999 Apr; 38(16):5147-54. PubMed ID: 10213620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand.
    Porter M; Schindler T; Kuriyan J; Miller WT
    J Biol Chem; 2000 Jan; 275(4):2721-6. PubMed ID: 10644735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphopeptide occupancy and photoaffinity cross-linking of the v-Src SH2 domain attenuates tyrosine kinase activity.
    Garcia P; Shoelson SE; Drew JS; Miller WT
    J Biol Chem; 1994 Dec; 269(48):30574-9. PubMed ID: 7527032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced phosphorylation of Src family kinase substrates containing SH2 domain binding sites.
    Pellicena P; Stowell KR; Miller WT
    J Biol Chem; 1998 Jun; 273(25):15325-8. PubMed ID: 9624111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
    Lerner EC; Smithgall TE
    Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
    Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
    EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Self-Binding Peptides as a Novel Strategy To Regulate Protein Activity and Function: A Case Study on the Proto-oncogene Tyrosine Protein Kinase c-Src.
    Bai Z; Hou S; Zhang S; Li Z; Zhou P
    J Chem Inf Model; 2017 Apr; 57(4):835-845. PubMed ID: 28345935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity Src-SH2 ligands which do not activate Tyr(527)-phosphorylated Src in an experimental in vivo system.
    Mandine E; Jean-Baptiste V; Vayssière B; Gofflo D; Bénard D; Sarubbi E; Deprez P; Baron R; Superti-Furga G; Lesuisse D
    Biochem Biophys Res Commun; 2002 Oct; 298(2):185-92. PubMed ID: 12387813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions.
    Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK
    J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability and peptide binding specificity of Btk SH2 domain: molecular basis for X-linked agammaglobulinemia.
    Tzeng SR; Pai MT; Lung FD; Wu CW; Roller PP; Lei B; Wei CJ; Tu SC; Chen SH; Soong WJ; Cheng JW
    Protein Sci; 2000 Dec; 9(12):2377-85. PubMed ID: 11206059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Src protein-tyrosine kinase structure and regulation.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Nov; 324(4):1155-64. PubMed ID: 15504335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative modes of tyrosyl phosphopeptide binding to a Src family SH2 domain: implications for regulation of tyrosine kinase activity.
    Ladbury JE; Hensmann M; Panayotou G; Campbell ID
    Biochemistry; 1996 Aug; 35(34):11062-9. PubMed ID: 8780508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.